Therapy for acute basilar artery occlusion: a systematic review and meta-analysis [version 1; peer review: 2 approved]

Purpose: This study aims to analyse the efficacy of different treatment methods for acute basilar artery occlusion, with an emphasis placed on evaluating the latest treatment methods. Method:  A systematic review and meta-analysis was performed to analyse the current data on the therapies available...

Full description

Bibliographic Details
Main Authors: Kevin Sheng, Marcus Tong
Format: Article
Language:English
Published: F1000 Research Ltd 2019-02-01
Series:F1000Research
Online Access:https://f1000research.com/articles/8-165/v1
id doaj-5cb3d66ac03d46aa90d53e1d607b92d4
record_format Article
spelling doaj-5cb3d66ac03d46aa90d53e1d607b92d42020-11-25T03:25:21ZengF1000 Research LtdF1000Research2046-14022019-02-01810.12688/f1000research.18042.119731Therapy for acute basilar artery occlusion: a systematic review and meta-analysis [version 1; peer review: 2 approved]Kevin Sheng0Marcus Tong1Faculty of Medicine, Macquarie University, Macquarie Park, NSW, 2109, AustraliaFaculty of Medicine, Macquarie University, Macquarie Park, NSW, 2109, AustraliaPurpose: This study aims to analyse the efficacy of different treatment methods for acute basilar artery occlusion, with an emphasis placed on evaluating the latest treatment methods. Method:  A systematic review and meta-analysis was performed to analyse the current data on the therapies available for treating acute basilar artery occlusion. Results: A total of 102 articles were included. The weighted pooled rate of mortality was 43.16% (95% CI 38.35-48.03%) in the intravenous thrombolysis group, 45.56% (95% CI 39.88-51.28) in the intra-arterial thrombolysis group, and 31.40% (95% CI 28.31-34.56%) for the endovascular thrombectomy group. The weighted pooled rate of Modified Ranking Score (mRS) 0-2 at 3 months was 31.40 (95% CI 28.31-34.56%) in the IVT group, 28.29% (95% CI 23.16-33.69%) in the IAT group, and 35.22% (95% CI 32.39-38.09%) for the EVT group. Meta-analyses were also done for the secondary outcomes of recanalization and symptomatic haemorrhage. There was no difference between stent retriever and thrombo-aspiration thrombectomy on subgroup analysis in both clinical outcome and safety profile. Limitations: The included studies were observational in nature. There was significant heterogeneity in some of the outcomes. Conclusions:  Superior outcomes and better recanalization rates for acute basilar occlusion were seen with patients managed with endovascular thrombectomy when compared with either intravenous and/or intraarterial thrombolysis. No superiority of stent‐retrievers over thrombo-aspiration thrombectomy was seen.https://f1000research.com/articles/8-165/v1
collection DOAJ
language English
format Article
sources DOAJ
author Kevin Sheng
Marcus Tong
spellingShingle Kevin Sheng
Marcus Tong
Therapy for acute basilar artery occlusion: a systematic review and meta-analysis [version 1; peer review: 2 approved]
F1000Research
author_facet Kevin Sheng
Marcus Tong
author_sort Kevin Sheng
title Therapy for acute basilar artery occlusion: a systematic review and meta-analysis [version 1; peer review: 2 approved]
title_short Therapy for acute basilar artery occlusion: a systematic review and meta-analysis [version 1; peer review: 2 approved]
title_full Therapy for acute basilar artery occlusion: a systematic review and meta-analysis [version 1; peer review: 2 approved]
title_fullStr Therapy for acute basilar artery occlusion: a systematic review and meta-analysis [version 1; peer review: 2 approved]
title_full_unstemmed Therapy for acute basilar artery occlusion: a systematic review and meta-analysis [version 1; peer review: 2 approved]
title_sort therapy for acute basilar artery occlusion: a systematic review and meta-analysis [version 1; peer review: 2 approved]
publisher F1000 Research Ltd
series F1000Research
issn 2046-1402
publishDate 2019-02-01
description Purpose: This study aims to analyse the efficacy of different treatment methods for acute basilar artery occlusion, with an emphasis placed on evaluating the latest treatment methods. Method:  A systematic review and meta-analysis was performed to analyse the current data on the therapies available for treating acute basilar artery occlusion. Results: A total of 102 articles were included. The weighted pooled rate of mortality was 43.16% (95% CI 38.35-48.03%) in the intravenous thrombolysis group, 45.56% (95% CI 39.88-51.28) in the intra-arterial thrombolysis group, and 31.40% (95% CI 28.31-34.56%) for the endovascular thrombectomy group. The weighted pooled rate of Modified Ranking Score (mRS) 0-2 at 3 months was 31.40 (95% CI 28.31-34.56%) in the IVT group, 28.29% (95% CI 23.16-33.69%) in the IAT group, and 35.22% (95% CI 32.39-38.09%) for the EVT group. Meta-analyses were also done for the secondary outcomes of recanalization and symptomatic haemorrhage. There was no difference between stent retriever and thrombo-aspiration thrombectomy on subgroup analysis in both clinical outcome and safety profile. Limitations: The included studies were observational in nature. There was significant heterogeneity in some of the outcomes. Conclusions:  Superior outcomes and better recanalization rates for acute basilar occlusion were seen with patients managed with endovascular thrombectomy when compared with either intravenous and/or intraarterial thrombolysis. No superiority of stent‐retrievers over thrombo-aspiration thrombectomy was seen.
url https://f1000research.com/articles/8-165/v1
work_keys_str_mv AT kevinsheng therapyforacutebasilararteryocclusionasystematicreviewandmetaanalysisversion1peerreview2approved
AT marcustong therapyforacutebasilararteryocclusionasystematicreviewandmetaanalysisversion1peerreview2approved
_version_ 1724597302715219968